RESUMEN
Cystic fibrosis patients' lungs are chronically colonized by multiple microbial species capable of forming biofilms. This study aimed to characterize the polymicrobial biofilm formed by Candida spp. and S. aureus, co-isolated from sputum samples of cystic fibrosis patients regarding microbial density, metabolic activity, and structure. 67 samples from 28 patients were collected with a 96% alteration rate. 34% showed alterations by both Candida spp. and Gram-positive bacteria, predominantly Candida spp. and S. aureus in 77% of cases, accounting for 6 associations. Biofilm biomass was quantified using the crystal violet assay, and metabolic activity was assessed using the MTT reduction assay. Scanning electron microscopy analyzed the C. tropicalis/S. aureus24 biofilm architecture. Candida spp. isolates demonstrated the ability to form mixed biofilms with S. aureus. The C. tropicalis/S. aureus24 association exhibited the highest production of biofilm and metabolic activity, along with the C. albicans17/C. rugosa/S. aureus7 in both single and mixed biofilms.
Asunto(s)
Biopelículas , Candida , Fibrosis Quística , Esputo , Staphylococcus aureus , Biopelículas/crecimiento & desarrollo , Humanos , Fibrosis Quística/microbiología , Fibrosis Quística/complicaciones , Staphylococcus aureus/aislamiento & purificación , Staphylococcus aureus/fisiología , Argelia , Candida/aislamiento & purificación , Candida/clasificación , Candida/fisiología , Esputo/microbiología , Infecciones Estafilocócicas/microbiología , Coinfección/microbiología , Femenino , Masculino , Adulto , Candidiasis/microbiología , Microscopía Electrónica de Rastreo , Adulto Joven , Adolescente , NiñoRESUMEN
Fungal-bacterial infections are being increasingly recognized in clinical settings, and the interaction between these species in polymicrobial biofilms often lead to infections that are highly resistant to treatment. In this in vitro study, we analyzed the formation of mixed biofilms using clinically isolated Candida parapsilosis and Enterobacter cloacae. Additionally, we assessed the potential of conventional antimicrobials, both alone and in combination, for treating polymicrobial biofilms built by these human pathogens. Our results demonstrate that C. parapsilosis and E. cloacae are capable of forming mixed biofilms, as confirmed by scanning electron microscopy. Interestingly, we found that colistin alone or in combination with antifungal drugs was highly effective reducing up to 80% of the total biomass of polymicrobial biofilms.